comparison of drug nalbuphine and tramadol used for shivering after spinal anaesthesia
Phase 3
Completed
- Conditions
- Health Condition 1: -
- Registration Number
- CTRI/2018/02/012125
- Lead Sponsor
- Department of anaesthesiologyIGIMSPatna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
1.Patients of ASA physical status I &II
2.Age between 18-50 yrs of age of either sex who have undergone routine general, orthopaedic, or gynaecological and obstetrical surgery under spinal anaesthesia.
3.Post anaesthetic shivering occurring within 10min of admission to recovery room
Exclusion Criteria
1. <18 yrs of age& >50 yr of age
2.Post anaesthetic shivering occurring after 10 min of admission to recovery room
3.Known hyperthyroidism, cardiopulmonary or neuromuscular pathology
4.Patients with contraindication for the use of Nalbuphine and Tramadol will not be included
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To compare the effectiveness of intravenous nalnupine and tramadol for post spinal anaesthesia shivering. <br/ ><br>Timepoint: 0min,5min,10min,15min,20min,25min,30min
- Secondary Outcome Measures
Name Time Method 1.To study the adverse effects if any. <br/ ><br>2.To compare any haemodynamic changes <br/ ><br>Timepoint: 0min,5min,10min,15min,20min,25min,30min